Skip to main content
Medtide Inc. logo

Medtide Inc. — Investor Relations & Filings

Ticker · 3880 LEI · 254900EYF65J0WV87333 HKEX Manufacturing
Open in API
Filings indexed 39 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country CN China
Listing HKEX 3880

About Medtide Inc.

https://medtideinc.com

Medtide Inc. is a specialized, peptide-focused Contract Research, Development, and Manufacturing Organization (CRDMO). It offers full-cycle services, including peptide New Chemical Entity (NCE) discovery synthesis (CRO services), preclinical research, clinical development, and commercial production (CDMO services). The company's primary focus is providing Active Pharmaceutical Ingredients (APIs) to pharmaceutical clients, leveraging expertise across the entire peptide drug development lifecycle.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2026
Regulatory Filings
2026-05-06 English
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Regulatory Filings
2026-04-23 English
2025 ANNUAL REPORT
Annual Report Classification · 1% confidence The document is explicitly titled '2025 ANNUAL REPORT' and contains comprehensive sections including a Chairwoman's Statement, Management Discussion and Analysis, Financial Summary, and full Consolidated Financial Statements (Profit or Loss, Comprehensive Income, Financial Position, Changes in Equity, Cash Flows, and Notes). It covers the full fiscal year ending December 31, 2025, and provides detailed financial and operational performance data, fitting the definition of an Annual Report (10-K). FY 2025
2026-04-23 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2026
Share Issue/Capital Change Classification · 1% confidence The document is an HKEX Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” detailing movements in authorised/registered share capital, issued shares, public float confirmations, and conversion of unlisted shares to H shares. It is a regulatory submission to record share capital changes rather than an earnings report, management commentary, or one-off announcement of a report. This falls under the category of Share Issue/Capital Change (Code: SHA).
2026-04-08 English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY AND ABOLISHMENT OF THE SUPERVISORY COMMITTEE
Governance Information Classification · 1% confidence The document is an official listing announcement by the Board of Medtide Inc. regarding proposed amendments to its Articles of Association and the abolishment of its Supervisory Committee, to be approved at the upcoming AGM by special resolution. It focuses on corporate governance structure changes (internal rules and board/committee arrangements). This aligns with the Governance Information category, which covers reports and announcements detailing a company’s internal rules, board structure, and related governance practices.
2026-03-30 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025
Earnings Release Classification · 1% confidence The document is a preliminary “Annual Results Announcement for the Year Ended December 31, 2025” under the Hong Kong Listing Rules, including audited financial highlights, management discussion and analysis, and business review. It is not the full statutory annual report (10-K) but the initial release of the year-end financial results, matching the Earnings Release (ER) category. FY 2025
2026-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.